Equities Analysts Set Expectations for RVMD Q1 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities researchers at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Revolution Medicines in a research report issued on Monday, March 3rd. HC Wainwright analyst R. Burns now expects that the company will post earnings per share of ($1.09) for the quarter, down from […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities researchers at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Revolution Medicines in a research report issued on Monday, March 3rd. HC Wainwright analyst R. Burns now expects that the company will post earnings per share of ($1.09) for the quarter, down from […]
